Helping older men with prostate cancer make decisions about active surveillance
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
This study is testing a new tool to help older men with localized prostate cancer and their caregivers make better decisions about their active surveillance options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 45 (estimated) |
| Ages | 65 Years and up |
| Sex | Male |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT05497024 on ClinicalTrials.gov |
What this trial studies
This project focuses on developing and testing an educational decision aid designed to assist older men with localized prostate cancer who are on active surveillance. The aim is to help these patients, along with their caregivers and healthcare providers, make informed choices about whether to continue or de-escalate their surveillance testing. The study involves cognitive and usability testing of the decision aid to ensure it meets the needs of patients and clinicians effectively. By refining this tool, the project seeks to enhance shared decision-making in prostate cancer care.
Who should consider this trial
Good fit: Ideal candidates for this study are men aged 65 or older who have been diagnosed with localized prostate cancer and have been on active surveillance for at least 12 months.
Not a fit: Patients receiving treatment for another cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could empower patients to make more informed decisions regarding their prostate cancer management, potentially improving their quality of life.
How similar studies have performed: Other studies have shown promise in using decision aids for cancer management, indicating that this approach could be beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Patients Inclusion Criteria: 1. Males aged 65 or older 2. Diagnosis of localized prostate cancer 3. On active surveillance for 12 or more months 4. Fluent in English Exclusion Criteria: 1\. Receiving treatment for another cancer (primary or recurrence) Caregivers Inclusion Criteria: 1. Aged 18 or older 2. Fluent in English 3. Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion) Exclusion Criteria: 4. None Clinicians Inclusion Criteria: 1. Aged 18 or older 2. Fluent in English 3. Provides clinical care for patients with prostate cancer (e.g. medical oncologists, urologists, radiation oncologists, nurse practitioners, physician assistants) Exclusion Criteria: 1\. None
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Lisa Lowenstein, MD — M.D. Anderson Cancer Center
- Study coordinator: Lisa Lowenstein, MD
- Email: deescalatepca@mdanderson.org
- Phone: 713-563-0020
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.